| Sources | Names Used |
|---|---|
| CTRPv2 | ML334 diastereomer |
| PharmacoGx | ML334 diastereomer |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UBN1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | PLXNC1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | NFIC | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | ATXN7L3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | SPRR2D | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | BIVM-ERCC5 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | GNB1L | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | H2AFY | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | ICOS | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | MED8 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
